Mitsubishi UFJ Asset Management’s AngioDynamics ANGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANGO
SFM
AC
RA
BH
WCM
Mitsubishi UFJ Asset Management's ANGO Position: Q2 2026 in Review
Mitsubishi UFJ Asset Management increased its AngioDynamics (ANGO) stake by 36% in Q2 2026, buying an estimated $191K and bringing the position to 63,729 shares worth $829K. The position accounts for ﹤0.01% of the portfolio, ranked #866.
Mitsubishi UFJ Asset Management first reported a position in ANGO in Q4 2018 and has held it in 31 quarters since. The position peaked at $5.32M in Q1 2021. 162 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.
- Mitsubishi UFJ Asset Management held 63,729 shares of AngioDynamics worth $829K as of Q2 2026.
- Mitsubishi UFJ Asset Management bought 16,804 AngioDynamics shares in Q2 2026, an estimated $191K.
- AngioDynamics made up ﹤0.01% of Mitsubishi UFJ Asset Management's portfolio in Q2 2026, its #866 holding.
- Mitsubishi UFJ Asset Management first reported a position in AngioDynamics in Q4 2018 and has held it in 31 quarters since.
- Mitsubishi UFJ Asset Management's AngioDynamics position peaked at $5.32M in Q1 2021.
- 162 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.
Based on Mitsubishi UFJ Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.